Jack Shiansong Li
About Jack Shiansong Li
Jack Shiansong Li is the Associate Director of Biostatistics at Bristol Myers Squibb in New Jersey, with over twenty years of experience in the pharmaceutical industry, particularly in hematology and oncology.
Title: Associate Director Biostatistics
Jack Shiansong Li holds the position of Associate Director, Biostatistics at Bristol Myers Squibb in New Jersey, United States. In this role, he is responsible for overseeing biostatistical projects, providing statistical support for clinical trials, and ensuring compliance with regulatory requirements.
Company: Bristol Myers Squibb
Jack Shiansong Li is currently employed at Bristol Myers Squibb as the Associate Director of Biostatistics. His position involves extensive collaboration with various departments to support clinical development and regulatory submission efforts for the company's products.
Previous Experience at Celgene
Prior to joining Bristol Myers Squibb, Jack Shiansong Li worked at Celgene in several capacities. From 2014 to 2019, he served as an Associate Director. Before that, he held the positions of Principal Statistician from 2011 to 2014, and Consultant Statistician from 2009 to 2011. His tenure at Celgene focused on biostatistics for clinical trials and regulatory submission processes.
Educational Background
Jack Shiansong Li earned his DrPH in Biostatistics from Rutgers University, where he studied from 2007 to 2014. He also holds two master's degrees from Louisiana State University, one in Applied Statistics and the other in Forest Biometrics, both obtained between 1996 and 1998. His advanced education provided a robust foundation for his career in biostatistics.
Experience in Regulatory Submissions
Jack Shiansong Li has extensive experience in regulatory submissions, including NDA, BLA, and MAA processes. He has interacted with major health authorities such as the FDA and EMA, contributing to successful regulatory approvals and clinical development of various pharmaceutical products.